As a result of a large randomized, controlled trial (and experience during the first 15 years of the AIDS epidemic), standard guidelines for treatment of cryptococcal meningitis recommend 2 weeks of ...

This double-blind trial enrolled adults with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All patients received combination antifungal therapy of ...

Meningitis is an infection affecting the membranes that line the skull and spinal cord. Cryptococcal meningitis is a type of meningitis caused by a fungus called Cryptococcus. This type of meningitis ...

Cryptococcus is a yeast, which is a kind of fungus. This yeast infects those with poor immunity, like people with HIV. Cryptococcus has a liking for the nervous system, and it often causes meningitis ...

Experts aim to halve the number of deaths from a type of meningitis by changing drug treatment as a result of a new medical study. The fungal infection cryptococcal meningitis is responsible for more ...

Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)–related death in sub-Saharan Africa. Whether a treatment regimen that includes a single high dose of liposomal ...

International HIV experts have reported approximately 250,000 fungal meningitis cases annually, in the AIDS report, sub-Saharan Africa contributing 73% of cases. This photomicrograph depicts ...

A team of University of Minnesota Medical School researchers successfully tested a new antifungal therapy to treat fungal meningitis. The trial results were published in Clinical Infectious Diseases.

Crytococcal meningitis is a deadly invasive fungal infection which affects hundreds of thousands of HIV patients in the late stage of their disease every year. Crytococcal meningitis is a deadly ...

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by clinical trial results published in eLife. The study finds that adding tamoxifen to standard ...

Several immune cells help fungi infect the brain and cause meningitis when they should be doing the exact opposite. From the University of Sydney, researchers investigate the immune system’s ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VT-1129 for the ...